| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Judith Eschbach, Karin M Danze. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Neuro-degenerative diseases. vol 14. issue 1. 2015-02-12. PMID:24080741. |
parkinson's disease is a common neurodegenerative disease characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of α-synuclein aggregates found in lewy bodies throughout the brain. |
2015-02-12 |
2023-08-12 |
mouse |
| Sabrina M Heman-Ackah, Martina Hallegger, Mahendra S Rao, Matthew J A Woo. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Frontiers in molecular neuroscience. vol 6. 2014-06-24. PMID:24312000. |
parkinson's disease (pd) is a debilitating neurodegenerative disease characterized primarily by the selective death of dopaminergic (da) neurons in the substantia nigra pars compacta of the midbrain. |
2014-06-24 |
2023-08-12 |
Not clear |
| Gabriela Mercado, Pamela Valdés, Claudio Het. An ERcentric view of Parkinson's disease. Trends in molecular medicine. vol 19. issue 3. 2013-09-19. PMID:23352769. |
parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta and the accumulation of intracellular inclusions containing α-synuclein (αsyn). |
2013-09-19 |
2023-08-12 |
human |
| Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc, Kursad Gen. Inflammation in Parkinson's disease. Advances in protein chemistry and structural biology. vol 88. 2012-11-13. PMID:22814707. |
parkinson's disease (pd) is a common neurodegenerative disease that is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2012-11-13 |
2023-08-12 |
Not clear |
| Mercedes Unzeta, Elisenda San. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease. International review of neurobiology. vol 100. 2012-07-24. PMID:21971010. |
parkinson's disease (pd) is a neurodegenerative disease that is characterized by preferential loss of dopaminergic neurons in the substantia nigra pars compacta, leading to declining levels of dopamine in the striatum. |
2012-07-24 |
2023-08-12 |
Not clear |
| Hironori Yokoyama, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Arak. Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease. Acta neurobiologiae experimentalis. vol 71. issue 2. 2011-11-03. PMID:21731080. |
pd is well known to be a chronic and progressive neurodegenerative disease produced by a selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2011-11-03 |
2023-08-12 |
mouse |
| Tito Calì, Denis Ottolini, Marisa Brin. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease. BioFactors (Oxford, England). vol 37. issue 3. 2011-10-14. PMID:21674642. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta (snpc) and the presence of intracytoplasmatic inclusions known as lewy bodies, largely composed of alpha-synuclein (α-syn). |
2011-10-14 |
2023-08-12 |
Not clear |
| Yue Yong, Hanqing Ding, Zhiqin Fan, Jia Luo, Zun-Ji K. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease. Neurochemical research. vol 36. issue 3. 2011-05-19. PMID:21203835. |
parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by the pathological loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2011-05-19 |
2023-08-12 |
human |
| Jaime N Guzman, Javier Sanchez-Padilla, David Wokosin, Jyothisri Kondapalli, Ema Ilijic, Paul T Schumacker, D James Surmeie. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. vol 468. issue 7324. 2011-01-11. PMID:21068725. |
parkinson's disease is a pervasive, ageing-related neurodegenerative disease the cardinal motor symptoms of which reflect the loss of a small group of neurons, the dopaminergic neurons in the substantia nigra pars compacta (snc). |
2011-01-11 |
2023-08-12 |
mouse |
| Ji Won Um, Eunju Im, Hyun Jung Lee, Boram Min, Lang Yoo, Jiho Yoo, Hermann Lübbert, Christine Stichel-Gunkel, Hyun-Soo Cho, Jong Bok Yoon, Kwang Chul Chun. Parkin directly modulates 26S proteasome activity. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 35. 2010-09-20. PMID:20810900. |
parkinson's disease (pd) is a common neurodegenerative disease that involves the deterioration of dopaminergic neurons in the substantia nigra pars compacta. |
2010-09-20 |
2023-08-12 |
Not clear |
| Olivier Preynat-Seauve, Pierre R Burkhard, Jean Villard, Walter Zingg, Nathalie Ginovart, Anis Feki, Michel Dubois-Dauphin, Samia A Hurst, Alex Mauron, Marisa Jaconi, Karl-Heinz Kraus. Pluripotent stem cells as new drugs? The example of Parkinson's disease. International journal of pharmaceutics. vol 381. issue 2. 2010-02-04. PMID:19782880. |
it is one of the most prevalent neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2010-02-04 |
2023-08-12 |
Not clear |
| Jin Young Shin, Hyun-Jung Park, Young Hwan Ahn, Phil Hyu Le. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Journal of neurochemistry. vol 111. issue 4. 2009-11-06. PMID:19765187. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by selective loss of dopaminergic neurons in the pars compacta of the substantia nigra. |
2009-11-06 |
2023-08-12 |
mouse |
| Daniela Moniz Arduíno, A Raquel Esteves, Sandra M Cardoso, Catarina R Oliveir. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease. Neurochemistry international. vol 55. issue 5. 2009-10-26. PMID:19375464. |
sporadic parkinson's disease (pd) is a progressive neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta. |
2009-10-26 |
2023-08-12 |
Not clear |
| Julia Fuchs, Jakob C Mueller, Peter Lichtner, Claudia Schulte, Marita Munz, Daniela Berg, Ullrich Wüllner, Thomas Illig, Manu Sharma, Thomas Gasse. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiology of aging. vol 30. issue 5. 2009-06-22. PMID:17905480. |
parkinson's disease (pd) is a progressive neurodegenerative disease with typical motor symptoms due to the preferential loss of midbrain dopaminergic (mda) neurons in the substantia nigra pars compacta. |
2009-06-22 |
2023-08-12 |
Not clear |
| Paula Luciana Scalzo, Nilo Ikuta, Francisco Cardoso, Andrea Regner, Antônio Lúcio Teixeir. Quantitative plasma DNA analysis in Parkinson's disease. Neuroscience letters. vol 452. issue 1. 2009-06-11. PMID:19444939. |
parkinson disease (pd) is a neurodegenerative disease resulting from the loss of the dopaminergic neurons from the substantia nigra pars compacta (snpc). |
2009-06-11 |
2023-08-12 |
human |
| Smitha Karunakaran, Uzma Saeed, Mamata Mishra, R Khader Valli, Shanker Datt Joshi, Durga Praveen Meka, Pankaj Seth, Vijayalakshmi Ravindranat. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 28. issue 47. 2009-06-09. PMID:19020042. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the degeneration of the dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2009-06-09 |
2023-08-12 |
mouse |
| Samad Nadri, Masoud Soleimani, Zahra Mobarra, Sepideh Amin. Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells. Biochemical and biophysical research communications. vol 377. issue 2. 2008-12-05. PMID:18851950. |
parkinson's disease (pd) is neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2008-12-05 |
2023-08-12 |
human |
| Chun-Yao Lee, Chien-Hsing Lee, Chien-Cheng Shih, Horng-Huei Lio. Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta. Biochemical pharmacology. vol 76. issue 9. 2008-11-05. PMID:18761327. |
parkinson's disease (pd) is a neurodegenerative disease that mainly affects dopaminergic (da-ergic) neurons in the substantia nigra pars compacta (snc). |
2008-11-05 |
2023-08-12 |
rat |
| Shaik Shavali, Donald A Sen. Synergistic neurotoxic effects of arsenic and dopamine in human dopaminergic neuroblastoma SH-SY5Y cells. Toxicological sciences : an official journal of the Society of Toxicology. vol 102. issue 2. 2008-04-10. PMID:18079140. |
parkinson's disease is an environmentally influenced, neurodegenerative disease of unknown origin that is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. |
2008-04-10 |
2023-08-12 |
human |
| Yi Wang, Sheng Chen, Dehua Yang, Wei-dong L. Stem cell transplantation: a promising therapy for Parkinson's disease. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 2. issue 3. 2008-02-25. PMID:18040857. |
parkinson's disease is one of the most common neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2008-02-25 |
2023-08-12 |
Not clear |